We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Scolds Supernus Pharmaceuticals Over Video Claims

Law360, New York (November 3, 2016, 3:49 PM EDT) -- A video from specialty drugmaker Supernus Pharmaceuticals Inc. wrongly implied that its anti-seizure medicine Oxtellar XR is approved for epilepsy and downplayed the risks of life-threatening side effects, according to a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.